Disease/Infection News

RSS

Elsevier launches Global Malaria Resource

Elsevier, the world-leading publisher of scientific, technical and medical information products and services, today announced the launch of Malaria Nexus, Elsevier's Global Malaria Resource, http://www.malarianexus.com.

11 Aug 2010

Study shows health care-associated invasive MRSA infections decrease among patients

An analysis of data from 2005 through 2008 of nine metropolitan areas in the U.S. indicates that health care-associated invasive methicillin-resistant Staphylococcus aureus infections decreased among patients with infections that began in the community or in the hospital, according to a study in the August 11 issue of JAMA.

11 Aug 2010

Advanced Life Sciences reaches SPA agreement with FDA for Restanza Phase 3 study

Advanced Life Sciences Holdings, Inc., a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, oncology and respiratory diseases, announced today that it has reached agreement with the United States Food and Drug Administration (FDA), under the Special Protocol Assessment (SPA) process, on the design of its planned Phase 3 study of its novel once-daily oral antibiotic Restanza to treat community acquired bacterial pneumonia (CABP). The trial is the first prospectively designed superiority study to be conducted in CABP.

11 Aug 2010

WHO declares end of H1N1 pandemic

"World Health Organisation Director-General Margaret Chan announced Tuesday the end of the [H1N1] swine flu pandemic, more than a year after it was declared," Agence France-Presse reports. "The world is no longer in phase 6 of influenza pandemic alert. We are now moving into the post-pandemic period," Chan said during a virtual press conference from Hong Kong, according to a WHO press release (8/10).

11 Aug 2010

NIAID launches clinical trials of dengue vaccine

After more than a decade of development, the National Institute of Allergy and Infectious Diseases (NIAID) has started clinical trials to test a vaccine to protect against the dengue virus, a product researchers hope may one day "help prevent a disease to which 2.5 billion people are exposed," CIDRAP News reports (Roos, 8/9).

11 Aug 2010

FDA approves longer Valcyte therapy for CMV disease in adult kidney transplant patients

Genentech, Inc., a member of the Roche Group, announced today that the U.S. Food and Drug Administration (FDA) approved increasing the length of therapy with Valcyte (valganciclovir hydrochloride) in adult kidney transplant patients at high risk for cytomegalovirus (CMV) disease.

11 Aug 2010

Opinions: HIV prevention research; Foreign aid; Sanitation; Aid, self-reliance

"Microbicides, vaccines and other new approaches will one day join proven HIV-prevention strategies, including condoms, male circumcision and clean needles. How soon that day comes will depend on whether funders and the scientific community can develop the more collaborative approaches to HIV prevention research needed to address this fast-moving epidemic," Global HIV Vaccine Enterprise leaders Alan Bernstein, executive director, and Peter Piot, chair, write in a Globe and Mail opinion piece.

11 Aug 2010

Vertex reports results from Phase 3 ILLUMINATE study of telaprevir-based therapy for hepatitis C

Vertex Pharmaceuticals Incorporated today announced results from the Phase 3 ILLUMINATE study, which was designed to evaluate whether there was any benefit to extending therapy from 24 to 48 weeks in people whose hepatitis C virus (HCV) was undetectable at weeks 4 and 12 of treatment (extended rapid viral response or eRVR).

10 Aug 2010

Acme Brazil distributes Unique by Natural Sensation condoms through Drogaria Onofre network

Acme Brasil Distribuidora e Importadora Ltda is pleased to announce that Unique by Natural Senastion brand of condoms (Unique) is now available in Drogaria Onofre. Unique is being sold in five megastores in the Onofre network, four in Sao Paulo and one in Porto Alegre.

10 Aug 2010

AHF launches new ad campaign 'President Obama, The War on AIDS Has Not Been Won'

As part of its ongoing advocacy efforts to spur President Obama and the Administration to do more on AIDS, AHF is rolling out an ad headlined "President Obama, The War on AIDS Has Not Been Won" which compares the amount of U.S. dollars spent fighting the global AIDS epidemic vs. the amount spent on the war in Afghanistan. The ad features a scale with the globe on one side and the words "Global War on AIDS: $6.5 billion in 2010" and a map of Afghanistan on the other side with the words "Afghanistan War: $102 billion in 2010."

10 Aug 2010

Scientists identify compound to inhibit wild-type HIV-1 protease

Drug resistance remains a major problem in combating HIV infection, but a different approach to drug development could be the answer.Current viral inhibitors target the HIV-1 protease function with a competitive mechanism. Writing in the BJ ChemBio Knowledge Environment of the Biochemical Journal, Max Chang and colleagues from the Scripps Research Institute, La Jolla, suggest that pharmaceutical companies look at compounds that use an allosteric non-competitive mechanism of inhibition.

10 Aug 2010

CQ Weekly reports on advocates' response to Obama administration's domestic, global HIV/AIDS efforts

CQ Weekly examines how HIV/AIDS advocates are "[i]Increasingly dissatisfied with [President Barack] Obama's approach, both at home and abroad." According to the article, some advocates say that Obama and congressional Democrats "have failed to show the political will and marshal the necessary resources" to fight HIV/AIDS.

10 Aug 2010

Three-year efficacy data on STELARA for psoriasis presented at American Academy of Dermatology meeting

New study findings showed that a majority of patients with moderate to severe plaque psoriasis who had a previous response to STELARA® (ustekinumab) sustained a clinical response for up to three years with continued treatment regardless of their body weight. Investigators also presented findings from an integrated safety analysis that included data from one Phase 2 and three Phase 3 trials in which treatment with STELARA demonstrated a favorable benefit-risk profile for up to three years of treatment, consistent with previous analyses.

10 Aug 2010

NIH begins human clinical testing for dengue virus vaccine

After more than a decade of development at the National Institutes of Health, a vaccine to prevent infection by the mosquito-borne dengue virus has begun human clinical testing. The vaccine was developed by scientists at the National Institute of Allergy and Infectious Diseases (NIAID) and is undergoing clinical study at the Johns Hopkins Bloomberg School of Public Health in Baltimore.

10 Aug 2010

Researchers find disparities among children suffering from repeated ear infections

Research has documented that ethnic and socioeconomic disparities exist among patients with conditions such as heart disease and diabetes. Now, a new study by researchers from UCLA and Harvard University has found disparities among children suffering from repeated ear infections. The findings, published in the August edition of the journal Laryngoscope, show that frequent ear infections plague white children and children living below the poverty level more than children of other racial or ethnic backrounds or income levels.

10 Aug 2010

H1N1 pandemic could be declared over soon, WHO's Chan says

The WHO's decision to declare the H1N1 (swine flu) pandemic officially over could come within weeks, according to WHO Director-General Margaret Chan, the Canadian Press reports.

10 Aug 2010

Increase of alcohol taxes can reduce alcohol-related deaths

Adjusting the alcohol tax in Florida to account for inflation since 1983 would prevent 600 to 800 deaths each year in that state from diseases caused by chronic heavy alcohol use, according to a new study from the University of Florida. The Florida legislature last increased alcohol taxes in 1983.

10 Aug 2010

FDA approves Pfizer's Prefilled Dual-Chamber Syringe for XYNTHA administration in hemophilia A patients

Pfizer Inc. announced today that the U.S. Food and Drug Administration has granted approval of the use of a Prefilled Dual-Chamber Syringe for administration of XYNTHA® Antihemophilic Factor (Recombinant) Plasma/Albumin-Free to hemophilia A patients. XYNTHA is a recombinant factor VIII product indicated for both the control and prevention of bleeding episodes in patients with hemophilia A (congenital factor VIII deficiency or classic hemophilia) and for surgical prophylaxis in patients with hemophilia A.

9 Aug 2010

Dr Reddy’s launches first generic darbepoetin alfa

Dr. Reddy's Laboratories Ltd. announced today the launch of Cresp® - the first generic darbepoetin alfa in the world, and the only darbepoetin alfa in India. Cresp® has been approved in India for the treatment of anemia due to chronic kidney disease and anemia due to chemotherapy.

9 Aug 2010

Myconostica announces CE marking for MycAssay Aspergillus and Pneumocystis on additional platforms

Myconostica Ltd, the UK-based medical diagnostic company developing and commercialising rapid and highly specific tests for life-threatening fungal infections, today announces the CE marking of its lead products MycAssay™ Aspergillus and MycAssay™ Pneumocystis on the Roche Lightcycler® 2.0 and Stratagene Mx3000 series platforms.

9 Aug 2010

Disease/Infection News

Elsevier launches Global Malaria Resource

Study shows health care-associated invasive MRSA infections decrease among patients

Advanced Life Sciences reaches SPA agreement with FDA for Restanza Phase 3 study

WHO declares end of H1N1 pandemic

NIAID launches clinical trials of dengue vaccine

FDA approves longer Valcyte therapy for CMV disease in adult kidney transplant patients

Opinions: HIV prevention research; Foreign aid; Sanitation; Aid, self-reliance

Vertex reports results from Phase 3 ILLUMINATE study of telaprevir-based therapy for hepatitis C

Acme Brazil distributes Unique by Natural Sensation condoms through Drogaria Onofre network

AHF launches new ad campaign 'President Obama, The War on AIDS Has Not Been Won'

Scientists identify compound to inhibit wild-type HIV-1 protease

CQ Weekly reports on advocates' response to Obama administration's domestic, global HIV/AIDS efforts

Three-year efficacy data on STELARA for psoriasis presented at American Academy of Dermatology meeting

NIH begins human clinical testing for dengue virus vaccine

Researchers find disparities among children suffering from repeated ear infections

H1N1 pandemic could be declared over soon, WHO's Chan says

Increase of alcohol taxes can reduce alcohol-related deaths

FDA approves Pfizer's Prefilled Dual-Chamber Syringe for XYNTHA administration in hemophilia A patients

Dr Reddy’s launches first generic darbepoetin alfa

Myconostica announces CE marking for MycAssay Aspergillus and Pneumocystis on additional platforms

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Latest News